Abbott Laboratories (NYSE:ABT) has recalled several models of its Proclaim and Infinity implantable neurostimulation devices over concerns that an external controller device may not be able to switch ...
"The WellnessPro Infinity™ will set an entirely new standard in the Bioelectronics marketplace" remarked Electromedical Founder and CEO, Matthew Wolfson. "There's nothing like it on the market in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback